Cargando…
Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
Autores principales: | Marengo, Barbara, Meta, Elda, Brullo, Chiara, Ciucis, Chiara De, Colla, Renata, Speciale, Andrea, Garbarino, Ombretta, Bruno, Olga, Domenicotti, Cinzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924827/ https://www.ncbi.nlm.nih.gov/pubmed/36780313 http://dx.doi.org/10.18632/oncotarget.28346 |
Ejemplares similares
-
Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2020) -
Pyrazolyl-Ureas as Interesting Scaffold in Medicinal Chemistry
por: Brullo, Chiara, et al.
Publicado: (2020) -
Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative
por: Morretta, Elva, et al.
Publicado: (2023) -
The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein kinase (DMPK)1 as a novel angiogenesis target
por: Meta, Elda, et al.
Publicado: (2017) -
The Pyrazolyl-Urea Gege3 Inhibits the Activity of ANXA1 in the Angiogenesis Induced by the Pancreatic Cancer Derived EVs
por: Belvedere, Raffaella, et al.
Publicado: (2021)